Status:
COMPLETED
Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
General Electric
Philips Healthcare
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions.
Detailed Description
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the vascular structures, abdomen, and pelv...
Eligibility Criteria
Inclusion
- male or non-pregnant female patient
- 18 years or older
- any ethnic background
- presenting to MRI for a clinically-ordered chest MRI exam.
Exclusion
- Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- Pregnant patients or patients who are lactating.
- A patient who is claustrophobic
Key Trial Info
Start Date :
May 2 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00738712
Start Date
May 2 2011
End Date
January 14 2020
Last Update
January 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health Center
Ann Arbor, Michigan, United States, 48109